Hong Kong · Delayed Price · Currency is HKD Sisram Medical Statistics
Total Valuation
Sisram Medical has a market cap or net worth of HKD 1.99 billion. The enterprise value is 2.04 billion.
| Market Cap | 1.99B |
| Enterprise Value | 2.04B |
Important Dates
The next estimated earnings date is Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
Sisram Medical has 468.34 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 468.34M |
| Shares Outstanding | 468.34M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 0.35% |
| Float | 133.16M |
Valuation Ratios
The trailing PE ratio is 12.33 and the forward PE ratio is 6.62.
| PE Ratio | 12.33 |
| Forward PE | 6.62 |
| PS Ratio | 0.73 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | 12.18 |
| P/OCF Ratio | 10.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.64, with an EV/FCF ratio of 12.48.
| EV / Earnings | 12.61 |
| EV / Sales | 0.75 |
| EV / EBITDA | 6.64 |
| EV / EBIT | 11.92 |
| EV / FCF | 12.48 |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.64 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | 2.26 |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 5.11% and return on invested capital (ROIC) is 2.60%.
| Return on Equity (ROE) | 5.11% |
| Return on Assets (ROA) | 2.17% |
| Return on Invested Capital (ROIC) | 2.60% |
| Return on Capital Employed (ROCE) | 4.08% |
| Revenue Per Employee | 2.61M |
| Profits Per Employee | 155,489 |
| Employee Count | 1,015 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Sisram Medical has paid 39.71 million in taxes.
| Income Tax | 39.71M |
| Effective Tax Rate | 17.08% |
Stock Price Statistics
The stock price has increased by +20.40% in the last 52 weeks. The beta is 1.02, so Sisram Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +20.40% |
| 50-Day Moving Average | 4.31 |
| 200-Day Moving Average | 4.84 |
| Relative Strength Index (RSI) | 42.79 |
| Average Volume (20 Days) | 510,162 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sisram Medical had revenue of HKD 2.71 billion and earned 161.71 million in profits. Earnings per share was 0.34.
| Revenue | 2.71B |
| Gross Profit | 1.65B |
| Operating Income | 171.74M |
| Pretax Income | 232.43M |
| Net Income | 161.71M |
| EBITDA | 259.31M |
| EBIT | 171.74M |
| Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 486.74 million in cash and 368.72 million in debt, with a net cash position of 118.02 million or 0.25 per share.
| Cash & Cash Equivalents | 486.74M |
| Total Debt | 368.72M |
| Net Cash | 118.02M |
| Net Cash Per Share | 0.25 |
| Equity (Book Value) | 3.83B |
| Book Value Per Share | 7.82 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was 190.21 million and capital expenditures -26.78 million, giving a free cash flow of 163.43 million.
| Operating Cash Flow | 190.21M |
| Capital Expenditures | -26.78M |
| Free Cash Flow | 163.43M |
| FCF Per Share | 0.35 |
Margins
Gross margin is 60.93%, with operating and profit margins of 6.33% and 5.96%.
| Gross Margin | 60.93% |
| Operating Margin | 6.33% |
| Pretax Margin | 8.56% |
| Profit Margin | 5.96% |
| EBITDA Margin | 9.55% |
| EBIT Margin | 6.33% |
| FCF Margin | 6.02% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 2.96%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 2.96% |
| Dividend Growth (YoY) | -20.25% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 45.87% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 2.82% |
| Earnings Yield | 8.12% |
| FCF Yield | 8.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sisram Medical has an Altman Z-Score of 2.28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.28 |
| Piotroski F-Score | 5 |